Prevalence and antimicrobial resistance profiles of respiratory microbial flora in African children with HIV-associated chronic lung disease

dc.contributor.authorAbotsi, Regina E.
dc.contributor.authorNicol, Mark P.
dc.contributor.authorMcHugh, Grace
dc.contributor.authorSimms, Victoria
dc.contributor.authorRehman, Andrea M.
dc.contributor.authorBarthus, Charmaine
dc.contributor.authorMbhele, Slindile
dc.contributor.authorMoyo, Brewster W.
dc.contributor.authorNgwira, Lucky G.
dc.contributor.authorMujuru, Hilda
dc.contributor.authorMakamure, Beauty
dc.contributor.authorMayini, Justin
dc.contributor.authorOdland, Jon Oyvind
dc.contributor.authorFerrand, Rashida A.
dc.contributor.authorDube, Felix S.
dc.date.accessioned2021-09-06T09:38:59Z
dc.date.available2021-09-06T09:38:59Z
dc.date.issued2021-02
dc.description.abstractBACKGROUND: HIV-associated chronic lung disease (CLD) is common among children living with HIV (CLWH) in sub- Saharan Africa, including those on antiretroviral therapy (ART). However, the pathogenesis of CLD and its possible association with microbial determinants remain poorly understood. We investigated the prevalence, and antibiotic susceptibility of Streptococcus pneumoniae (SP), Staphylococcus aureus (SA), Haemophilus influenzae (HI), and Moraxella catarrhalis (MC) among CLWH (established on ART) who had CLD (CLD+), or not (CLD-) in Zimbabwe and Malawi. METHODS: Nasopharyngeal swabs (NP) and sputa were collected from CLD+ CLWH (defined as forced-expiratory volume per second z-score < − 1 without reversibility post-bronchodilation with salbutamol), at enrolment as part of a randomised, placebo-controlled trial of azithromycin (BREATHE trial - NCT02426112), and from age- and sexmatched CLD- CLWH. Samples were cultured, and antibiotic susceptibility testing was conducted using disk diffusion. Risk factors for bacterial carriage were identified using questionnaires and analysed using multivariate logistic regression. RESULTS: A total of 410 participants (336 CLD+, 74 CLD-) were enrolled (median age, 15 years [IQR = 13–18]). SP and MC carriage in NP were higher in CLD+ than in CLD- children: 46% (154/336) vs. 26% (19/74), p = 0.008; and 14% (49/336) vs. 3% (2/74), p = 0.012, respectively. SP isolates from the NP of CLD+ children were more likely to be nonsusceptible to penicillin than those from CLD- children (36% [53/144] vs 11% [2/18], p = 0.036). Methicillin-resistant SA was uncommon [4% (7/195)]. In multivariate analysis, key factors associated with NP bacterial carriage included having CLD (SP: adjusted odds ratio (aOR) 2 [95% CI 1.1–3.9]), younger age (SP: aOR 3.2 [1.8–5.8]), viral load suppression (SP: aOR 0.6 [0.4–1.0], SA: 0.5 [0.3–0.9]), stunting (SP: aOR 1.6 [1.1–2.6]) and male sex (SA: aOR 1.7 [1.0– 2.9]). Sputum bacterial carriage was similar in both groups (50%) and was associated with Zimbabwean site (SP: aOR 3.1 [1.4–7.3], SA: 2.1 [1.1–4.2]), being on ART for a longer period (SP: aOR 0.3 [0.1–0.8]), and hot compared to rainy season (SP: aOR 2.3 [1.2–4.4]). CONCLUSIONS: CLD+ CLWH were more likely to be colonised by MC and SP, including penicillin-non-susceptible SP strains, than CLD- CLWH. The role of these bacteria in CLD pathogenesis, including the risk of acute exacerbations, should be further studied.en_ZA
dc.description.departmentSchool of Health Systems and Public Health (SHSPH)en_ZA
dc.description.librarianpm2021en_ZA
dc.description.sponsorshipGlobal Health and Vaccination Research (GLOBVAC) Programme of the Medical Research Council of Norway; Swedish International Development Cooperation Agency (SIDA) through Organisation of Women in Science for the developing world (OWSD) PhD Fellowship; Margaret McNamara Education Grants; L'Oréal UNESCO For Women in Science Fellowship; Australian National Health and Medical Research Council Investigator; UK Medical Research Council (MRC); UK Department for International Development (DFID); European Union; Wellcome Trust; National Research Foundation of South Africa; Future Leaders – African Independent Research (FLAIR) Fellowship; National Institute for Health Research (NIHR) Global Health Research Unit on Mucosal Pathogens using UK aid from the UK Government; University of Cape Town; Allergy Society of South Africa (ALLSA).en_ZA
dc.description.urihttp://www.biomedcentral.com/bmcinfectdisen_ZA
dc.identifier.citationAbotsi, R.E., Nicol, M.P., McHugh, G. et al. Prevalence and antimicrobial resistance profiles of respiratory microbial flora in African children with HIV-associated chronic lung disease. BMC Infectious Diseases 21, 216 (2021). https://doi.org/10.1186/s12879-021-05904-3.en_ZA
dc.identifier.issn1471-2334 (online)
dc.identifier.other10.1186/s12879-021-05904-3
dc.identifier.urihttp://hdl.handle.net/2263/81648
dc.language.isoenen_ZA
dc.publisherBMCen_ZA
dc.rights© The Author(s) 2021 Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License.en_ZA
dc.subjectStreptococcus pneumoniaeen_ZA
dc.subjectStaphylococcus aureusen_ZA
dc.subjectMoraxella catarrhalisen_ZA
dc.subjectHaemophilus influenzaeen_ZA
dc.subjectAntibiotic resistanceen_ZA
dc.subjectChronic lung diseaseen_ZA
dc.subjectHuman immunodeficiency virus (HIV)en_ZA
dc.subjectChronic lung disease (CLD)en_ZA
dc.subjectChildren living with HIV (CLWH)en_ZA
dc.subjectSub-Saharan Africa (SSA)en_ZA
dc.subjectAntiretroviral therapy (ART)en_ZA
dc.titlePrevalence and antimicrobial resistance profiles of respiratory microbial flora in African children with HIV-associated chronic lung diseaseen_ZA
dc.typeArticleen_ZA

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Abotsi_Prevalence_2021.pdf
Size:
702.29 KB
Format:
Adobe Portable Document Format
Description:
Article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.75 KB
Format:
Item-specific license agreed upon to submission
Description: